In patients with atherosclerosis and CH, interleukin-6 (IL-6) levels were elevated regardless of the specific driver mutation, whereas high-sensitivity C-reactive protein (hsCRP) levels were significantly increased only in those with ASXL1-CH. This evidence concerns the gene IL6 and atherosclerosis.